John H Abeles - Net Worth and Insider Trading
John H Abeles Net Worth
The estimated net worth of John H Abeles is at least $3 Million dollars as of 2025-04-17. John H Abeles is the Director of Davis Select U.S. Equity ETF and owns about 77,000 shares of Davis Select U.S. Equity ETF (DUSA) stock worth over $3 Million. John H Abeles is also the Director of Medite Cancer Diagnostics Inc and owns about 1,683,202 shares of Medite Cancer Diagnostics Inc (MDIT) stock worth over $0. Details can be seen in John H Abeles's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John H Abeles has not made any transactions after 2018-10-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of John H Abeles
John H Abeles Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John H Abeles owns 4 companies in total, including Medite Cancer Diagnostics Inc (MDIT) , Neurotrope Inc (NTRP) , and CombiMatrix Corp (CBMX) among others .
Click here to see the complete history of John H Abeles’s form 4 insider trades.
Insider Ownership Summary of John H Abeles
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MDIT | Medite Cancer Diagnostics Inc | 2018-10-11 | director |
| NTRP | Neurotrope Inc | 2015-11-13 | 10 percent owner |
| CBMX | CombiMatrix Corp | 2012-01-03 | director |
 | | 2005-12-06 | director |
John H Abeles Latest Holdings Summary
John H Abeles currently owns a total of 2 stocks. Among these stocks, John H Abeles owns 77,000 shares of Davis Select U.S. Equity ETF (DUSA) as of December 17, 2009, with a value of $3 Million and a weighting of 100%. John H Abeles also owns 1,683,202 shares of Medite Cancer Diagnostics Inc (MDIT) as of October 11, 2018, with a value of $0 and a weighting of 0%.
Latest Holdings of John H Abeles
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DUSA | Davis Select U.S. Equity ETF | 2009-12-17 | 77,000 | 40.05 | 3,083,465 |
| MDIT | Medite Cancer Diagnostics Inc | 2018-10-11 | 1,683,202 | 0.00 | 0 |
Holding Weightings of John H Abeles
John H Abeles Form 4 Trading Tracker
According to the SEC Form 4 filings, John H Abeles has made a total of 0 transactions in Davis Select U.S. Equity ETF (DUSA) over the past 5 years. The most-recent trade in Davis Select U.S. Equity ETF is the acquisition of 40,000 shares on December 17, 2009, which cost John H Abeles around $51,200.
According to the SEC Form 4 filings, John H Abeles has made a total of 0 transactions in Medite Cancer Diagnostics Inc (MDIT) over the past 5 years. The most-recent trade in Medite Cancer Diagnostics Inc is the acquisition of 266,667 shares on October 11, 2018, which cost John H Abeles around $21,333.
Insider Trading History of John H Abeles
- 1
John H Abeles Trading Performance
GuruFocus tracks the stock performance after each of John H Abeles's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John H Abeles is -76.11%. GuruFocus also compares John H Abeles's trading performance to market benchmark return within the same time period. The performance of stocks bought by John H Abeles within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how John H Abeles's insider trading performs compared to the benchmark.
Performance of John H Abeles
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -54.21 | | | | | |
| Relative Return to S&P 500(%) | -57.52 | | | | | |
John H Abeles Ownership Network
Ownership Network List of John H Abeles
Ownership Network Relation of John H Abeles
John H Abeles Owned Company Details
What does Medite Cancer Diagnostics Inc do?
Who are the key executives at Medite Cancer Diagnostics Inc?
John H Abeles is the director of Medite Cancer Diagnostics Inc. Other key executives at Medite Cancer Diagnostics Inc include and director & 10 percent owner Lewis William Austin Iv .
Medite Cancer Diagnostics Inc (MDIT) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Medite Cancer Diagnostics Inc (MDIT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Medite Cancer Diagnostics Inc (MDIT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Medite Cancer Diagnostics Inc (MDIT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Medite Cancer Diagnostics Inc Insider Transactions
John H Abeles Mailing Address
Above is the net worth, insider trading, and ownership report for John H Abeles. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, John H Abeles's mailing address is: 2365 Nw 41st Street Boca Raton Fl 33431.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
